Clinical Trials for Acquired Amegakaryocytic Thrombocytopenia

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

NCT ID: NCT06412497

This clinical trial, titled MT2023-20, is exploring a new treatment approach for patients with severe aplastic anemia and other related conditions that affect the bone marrow, such as paroxysmal no...